Supreme Court Asked If State Universities Are Exempt From Claims Under the False Claims Act

by Saul Ewing Arnstein & Lehr LLP


A professor at the University of Texas Health Science Center has petitioned the U.S. Supreme Court to determine the standard for imposing liability on state universities (and their related entities, such as hospitals and research centers) under the False Claims Act, 31 U.S.C. §§ 3729, et seq.  In King v. University of Texas Health Science Center, the U.S. Court of Appeals for the Fifth Circuit held that the Health Science Center, a hospital within the University of Texas System, is an “arm of the state,” and therefore both exempt from liability under the False Claims Act and immune from suit in federal court under the Eleventh Amendment.

The federal courts of appeal which have addressed this issue — whether a state university or related entity — have reached conflicting conclusions.  Because there is a split among the federal circuits, this increases the likelihood that the Supreme Court grant certiorari on this issue. 


In this case, a former associate professor at the University of Texas Health Science Center filed a qui tam (or whistleblower) claim under the False Claims Act (“FCA”), alleging that the University violated the Act by covering up the misconduct of a professor who received federal research grants. Under the FCA, liability will be imposed on “any person who . . .knowingly presents, or causes to be presented, a false or fraudulent claim for payment or approval” or “knowingly makes, uses, or causes to be made or used, a false record or statement material to a false or fraudulent claim.”  31 U.S.C. § 3729(a)(1)(A)-(B).

The whistleblower, Professor Terri King, worked in the Health Science Center’s Department of Internal Medicine from 2001 to 2005.  In 2001, she began working in a research lab under Dr. Dianna Milewicz’s supervision. According to King’s complaint, she began noticing discrepancies in Milewicz’s data in 2004.  King alleges that when she informed Milewicz about the discrepancies, she was retaliated against by receiving a “false and defamatory performance review” from Dr. Milewicz. King also alleges that she was retaliated against when she was reassigned to less favorable positions and eventually terminated.

In January 2011, King filed a qui tam lawsuit against the Health Science Center, alleging that Dr. Milewicz falsified research data and results.  King claims that the fraud was in connection with federally-funded research, and that Milewicz used falsified results in order to obtain federal funding.  King also alleged that the Center covered up Milewicz’s misconduct relating to federal research grants.  In addition, King asserted a retaliation and wrongful termination claim under the FCA’s anti-retaliation provision, 31 U.S.C. § 3730(h), alleging that she was retaliated against after notifying Dr. Milewicz of the alleged fraud. The United States, which has the right under the FCA to intervene in qui tam actions, declined to do so.

The U.S. District Court dismissed the whistleblower claim, concluding that the university hospital was an “arm of the state,” and therefore exempt from the FCA’s qui tam provisions.  The district court also held that the plaintiff’s retaliation claim was barred by the Eleventh Amendment’s “sovereign immunity” protection.  The district court’s reasoning was based on the Supreme Court’s decision in Vt. Agency of Natural Resources. v. United States (2000), which held that states (as well as state agencies) are not subject to liability under the False Claims Act because they are not a “person” within the meaning of that Act.

In November 2013, the Fifth Circuit affirmed the district court’s ruling that the Health Science Center is an “arm of the state,” and therefore not a “person” that can be held liable under the FCA.  The Fifth Circuit applied six factors to determine whether the center qualifies as an “arm of the state,” including: (1) whether state law characterizes the agency as an arm of the state; (2) the source of funds for the entity; (3) the degree of local autonomy by the entity; (4) whether the entity is concerned primarily with local, as opposed to statewide problems; (5) whether the entity has authority to sue, and be sued, in its own name; and (6) whether the entity has the right to hold and use property.  In applying these factors, the Fifth Circuit recognized:

            • The Health Science Center is part of the University of Texas, and the university is considered, under state statutory law, an “arm of the state.”  Texas law also recognizes that the Health Science Center is a “governmental unit.”

            • The Health Science Center receives significant funding from state sources.

            • The Health Science Center has limited autonomy.  A Board of Regents appointed by the Texas Governor is responsible for governing the University of Texas System, including the component institutions.  All Health Science Center contracts must be in accordance with board rules or specially approved by the Board of Regents. As a state agency, the Center is also required to follow specific accounting and financial reporting requirements.  In addition, the Board of Regents has the sole and exclusive management over the Center’s right to hold and use property.

            • The University of Texas System has locations throughout the state of Texas.  Although the Health Science Center’s facilities are confined to Houston, its research and education are created to benefit the citizens of the state, not just the local community.

For some of the above factors (particularly, the local/state factor), the Fifth Circuit framed the “entity” as the University of Texas, rather than the more narrow entity of the Health Science Center. In addition, despite the fact that the Health Science Center can sue, and be sued in its own name (a fact that King argues is important in demonstrating that the entity was not an “arm of the state”), the Court held this factor was outweighed by the others.

The Fifth Circuit also affirmed the dismissal of the FCA retaliation claim, holding that the Health Science Center is an “arm of the state” and therefore entitled to “sovereign immunity” under the Eleventh Amendment. Under the Eleventh Amendment, a state, or “arm of the state,” may generally not be sued for monetary relief.  Therefore, to the extent King was seeking monetary relief relating to her termination, that claim was barred by the Eleventh Amendment.

On January 31, 2014, King filed a petition with the U.S. Supreme Court for review.  While the Supreme Court has complete discretion in deciding whether to review cases, the fact that other federal courts of appeal have applied inconsistent standards in deciding this issue — whether state universities (or related entities) can be held liable under the FCA —increases the likelihood that the Supreme Court will decide this important issue.  For example, the Fourth and Fifth Circuits consider whether the entity is concerned primarily with local, as opposed to statewide concerns, while the Sixth Circuit considers whether the entity’s functions fall within the traditional purview of state or local government. While there is some overlap between these criteria, the broader approach by the Fourth and Fifth Circuit would lead to a greater range of entities considered as “arms of the state,” and therefore exempt under the FCA.

In her petition for review, King argues that the Fifth Circuit’s decision was wrong for the following reasons: (1) the Health Science Center has local autonomy; (2) the Center has $1 billion of its own assets (separate from the rest of the university); and (3) the Health Science Center is mostly concerned with local problems, rather than statewide.  King also argues that the courts incorrectly conflated the Health Science Center with the University of Texas, when the courts should have focused on the Health Science Center specifically, rather than the University as a whole.  King also asks the Supreme Court to either reverse its prior Stevens decision, or at least narrow the decision in order to “minimize the growing fraud in academic research.”


Qui Tam actions have long been pursued in the defense, pharmaceutical and healthcare industries.  More recently, counsel for plaintiffs have been looking to other industries to target including higher education.  With significant federal funds spent on research and financial aid, higher education may be susceptible to such claims.  If the Supreme Court grants certiorari in this case, the outcome will likely have a significant impact on state universities and their related entities.

Written by:

Saul Ewing Arnstein & Lehr LLP

Saul Ewing Arnstein & Lehr LLP on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up using*

Already signed up? Log in here

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Privacy Policy (Updated: October 8, 2015):

JD Supra provides users with access to its legal industry publishing services (the "Service") through its website (the "Website") as well as through other sources. Our policies with regard to data collection and use of personal information of users of the Service, regardless of the manner in which users access the Service, and visitors to the Website are set forth in this statement ("Policy"). By using the Service, you signify your acceptance of this Policy.

Information Collection and Use by JD Supra

JD Supra collects users' names, companies, titles, e-mail address and industry. JD Supra also tracks the pages that users visit, logs IP addresses and aggregates non-personally identifiable user data and browser type. This data is gathered using cookies and other technologies.

The information and data collected is used to authenticate users and to send notifications relating to the Service, including email alerts to which users have subscribed; to manage the Service and Website, to improve the Service and to customize the user's experience. This information is also provided to the authors of the content to give them insight into their readership and help them to improve their content, so that it is most useful for our users.

JD Supra does not sell, rent or otherwise provide your details to third parties, other than to the authors of the content on JD Supra.

If you prefer not to enable cookies, you may change your browser settings to disable cookies; however, please note that rejecting cookies while visiting the Website may result in certain parts of the Website not operating correctly or as efficiently as if cookies were allowed.

Email Choice/Opt-out

Users who opt in to receive emails may choose to no longer receive e-mail updates and newsletters by selecting the "opt-out of future email" option in the email they receive from JD Supra or in their JD Supra account management screen.


JD Supra takes reasonable precautions to insure that user information is kept private. We restrict access to user information to those individuals who reasonably need access to perform their job functions, such as our third party email service, customer service personnel and technical staff. However, please note that no method of transmitting or storing data is completely secure and we cannot guarantee the security of user information. Unauthorized entry or use, hardware or software failure, and other factors may compromise the security of user information at any time.

If you have reason to believe that your interaction with us is no longer secure, you must immediately notify us of the problem by contacting us at In the unlikely event that we believe that the security of your user information in our possession or control may have been compromised, we may seek to notify you of that development and, if so, will endeavor to do so as promptly as practicable under the circumstances.

Sharing and Disclosure of Information JD Supra Collects

Except as otherwise described in this privacy statement, JD Supra will not disclose personal information to any third party unless we believe that disclosure is necessary to: (1) comply with applicable laws; (2) respond to governmental inquiries or requests; (3) comply with valid legal process; (4) protect the rights, privacy, safety or property of JD Supra, users of the Service, Website visitors or the public; (5) permit us to pursue available remedies or limit the damages that we may sustain; and (6) enforce our Terms & Conditions of Use.

In the event there is a change in the corporate structure of JD Supra such as, but not limited to, merger, consolidation, sale, liquidation or transfer of substantial assets, JD Supra may, in its sole discretion, transfer, sell or assign information collected on and through the Service to one or more affiliated or unaffiliated third parties.

Links to Other Websites

This Website and the Service may contain links to other websites. The operator of such other websites may collect information about you, including through cookies or other technologies. If you are using the Service through the Website and link to another site, you will leave the Website and this Policy will not apply to your use of and activity on those other sites. We encourage you to read the legal notices posted on those sites, including their privacy policies. We shall have no responsibility or liability for your visitation to, and the data collection and use practices of, such other sites. This Policy applies solely to the information collected in connection with your use of this Website and does not apply to any practices conducted offline or in connection with any other websites.

Changes in Our Privacy Policy

We reserve the right to change this Policy at any time. Please refer to the date at the top of this page to determine when this Policy was last revised. Any changes to our privacy policy will become effective upon posting of the revised policy on the Website. By continuing to use the Service or Website following such changes, you will be deemed to have agreed to such changes. If you do not agree with the terms of this Policy, as it may be amended from time to time, in whole or part, please do not continue using the Service or the Website.

Contacting JD Supra

If you have any questions about this privacy statement, the practices of this site, your dealings with this Web site, or if you would like to change any of the information you have provided to us, please contact us at:

- hide
*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.